• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VENASEAL; AGENT, OCCLUDING, VASCULAR, PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VENASEAL; AGENT, OCCLUDING, VASCULAR, PERMANENT Back to Search Results
Patient Problems Erythema (1840); Pain (1994); Burning Sensation (2146); Swelling/ Edema (4577); Insufficient Information (4580); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 02/22/2024
Event Type  Injury  
Event Description
I underwent a vein ablation in my left leg for venous insufficiency.Two products were used which resulted in me experiencing side effects: varithena and venaseal.After these products were injected in my leg, i experienced severe pain, burning, redness of the skin, swelling in the calf area as well as a lump on the backside of my calf.When touching my calf, it feels as hard as a rock.Since the procedure, i have experienced no improvement in my symptoms.The procedure was intended to heal ulcers present on my leg, and 3 weeks later there has been no improvement.Both products appear to be ineffective.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENASEAL
Type of Device
AGENT, OCCLUDING, VASCULAR, PERMANENT
Manufacturer (Section D)
MEDTRONIC IRELAND
MDR Report Key18922391
MDR Text Key338110795
Report NumberMW5152926
Device Sequence Number1
Product Code PJQ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 03/14/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Was Device Available for Evaluation? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received03/15/2024
Patient Sequence Number1
Treatment
METOPROLOL. ; TARTRATE.; VARITHENA.
Patient Age72 YR
Patient SexFemale
Patient RaceWhite
-
-